Sherri C. Oberg

Sherri C. Oberg has 30 years of experience leading innovative life sciences companies through all stages of development. She has co-founded 3 companies, translating early-stage academic research into product development. She has raised over $300 million, including venture capital, an initial public offering, public equity, international partnerships, joint ventures, and philanthropic grants.

Sherri is currently CEO and co-founder of Particles for Humanity PBC, which is developing a stable form of vitamin A for large scale food fortification, a proven strategy for addressing micronutrient deficiencies at scale. Vitamin A deficiency is a devastating public health problem throughout sub-Saharan Africa and South Asia, where it is a leading cause of death in young children and night blindness in pregnant women. Particles for Humanity’s innovation is based on technology licensed from MIT and funding from the Bill & Melinda Gates Foundation.

Sherri is currently a Trustee at Dartmouth Hitchcock Medical Center, New Hampshire’s only academic medical center. She is also on the Board of Advisors of the Magnuson Center for Entrepreneurship at Dartmouth. For eight years, she served on the Board of Trustees at Dartmouth College, where she was Chair of the Audit Committee. For 20 years, she served on the Board of Overseers at the Amos Tuck School of Business Administration at Dartmouth. She has also served on the Board and Executive Committee of the Massachusetts Biotechnology Council. She is a recipient of the Dartmouth Alumni Award and the Tuck Overseers Medal. She received a BA from Dartmouth College and MBA from the Amos Tuck School of Business.